Positive Outcomes.
Positive Patient Stories.

About Paratek

Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. We develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that with the right people, the right knowledge and the right drug, we can make a difference in patients’ lives.

Mission & Vision

Our Mission

To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn every day decisions into everyday triumphs that advance our technology and strengthen Paratek.

Our Vision

To be a leading independent biopharmaceutical company providing novel life-saving products for life-threatening diseases or other public health threats.

Built on Values

Our company is built on values that guide our work, culture, communications, and actions.

"Antimicrobial resistance (AMR) is a critical, global public health issue and an ongoing pandemic. Efforts to combat AMR require a multi-pronged approach, including responsible antibiotic use, improved surveillance, research into new antibiotics, and policy changes to enable a vibrant marketplace that recognizes the life-saving value of novel antibiotics. Paratek is a biopharmaceutical company that is dedicated to addressing AMR, a critical concern for public health and national security."

Dr. Evan Loh
CEO, Paratek Pharmaceuticals

Our Product
NUZYRA®  is an FDA-approved tetracycline-class antibiotic designed to address a significant unmet need for adult patients with CABP and ABSSSI caused by susceptible bacteria.
About Nuzyra
Groundbreaking Innovators
A disciplined team with proven capabilities in developing and commercializing new treatment options for complex medical issues.

Meet Our Team
Powered by You
Our employees are experienced, committed, and driven to build a company that saves lives. Learn more about how you can join our team.
View Open Roles